Year: 2020

ACTON, Mass., Nov. 09, 2020 (GLOBE NEWSWIRE) — Psychemedics Corporation (NASDAQ:PMD) today announced third quarter financial results for the period ended September 30, 2020.The Company’s revenue for the quarter ended September 30, 2020 was $5.2 million versus $9.9 million for the quarter ended September 30, 2019, a decrease of 47%. Net loss for the quarter ended September 30, 2020 was $1.1 million or ($0.20) per diluted share, versus net income of $0.7 million or $0.12 per diluted share, for the comparable period last year. The Company’s revenue for the nine months ended September 30, 2020 was $16.0 million versus $29.0 million for the comparable period in 2019, a decrease of 45%. Net loss for the nine months ended September 30, 2020 was $3.3 million or ($0.60) per diluted share, versus net income of $2.1 million or $0.37 per diluted...

VANCOUVER, British Columbia, Nov. 09, 2020 (GLOBE NEWSWIRE) — Westport Fuel Systems Inc. (“Westport” or “the Company”) announced today that the Company has established an at-the-market equity offering program (the “ATM Program”) that allows the Company to issue up to US$50 million (or the equivalent in Canadian dollars) of common shares (“Common Shares”)  from treasury to the public from time to time, at the Company’s discretion and subject to regulatory requirements. Any Common Shares sold through the ATM Program will be sold at prevailing market prices when issued (i) in ordinary brokers’ transactions on the Nasdaq Global Select Market (“Nasdaq”) or another U.S. marketplace on which the Common Shares are listed, quoted or otherwise traded or (ii) in ordinary brokers’...

TORONTO, Nov. 09, 2020 (GLOBE NEWSWIRE) — Relay Medical Corp. (“Relay” or the “Company”) (CSE: RELA, OTC: RYMDF, Frankfurt: EIY2), a developer of MedTech innovation, announces that it has entered into a binding letter of intent (the “Letter of Intent”) with Proprietary Innovation Labs Inc. (“PIL”) relating to the exclusive sale and distribution of rapid diagnostic tests for COVID-19 (the “Products”). The binding LOI was signed November 9, 2020.Under the terms of the LOI agreement Relay Medical’s diagnostics subsidiary, HemoPalm Corp. will acquire the exclusive global rights excluding China to Proprietary Innovation Labs’ COVID-19 product line including CE approved antibody and antigen lateral flow rapid diagnostic tests (RDT).PIL has developed both antigen and antibody tests for the SARS-CoV-2 virus with its manufacturing partners....

– Firdapse® Third Quarter Net Revenues of $29.2 Million– Company Ends Third Quarter with $127.1 Million in Cash and Investments– U.S. Patent Issued for Firdapse® and Expires April 7, 2034– Firdapse® Approved in Canada in the Third Quarter and Recently Launched– Company to Host Quarterly Conference Call at 8:30 am ET TomorrowCORAL GABLES, Fla., Nov. 09, 2020 (GLOBE NEWSWIRE) — Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq:CPRX), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating, chronic neuromuscular and neurological diseases, today reported financial results for the third quarter ended September 30, 2020 and provided a business update.“I am pleased to report on a very productive third quarter and on our continued...

METTAWA, Ill., Nov. 09, 2020 (GLOBE NEWSWIRE) — Brunswick Corporation (NYSE: BC) and its industry leading brands, Mercury Marine, Boston Whaler, Sea Ray and Freedom Boat Club, all had a very successful 2020 Ft. Lauderdale International Boat Show.For the third consecutive year, Mercury Marine had the most outboard engines of any manufacturer at the show and increased its show market share for the fourth consecutive year, accounting for more than half of the total engines displayed at the 2020 show.Despite the significantly reduced show attendance, Boston Whaler reported increased year-over-year show sales on many of its leading models.  In addition, Sea Ray had a great show with many models selling at or above prior year results.  Sea Ray also announced the all-new 370 Sundancer which will officially launch in February 2021 and features...